Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Impact of pregnancy on abacavir pharmacokinetics
Brookie M. Best
, Mark Mirochnick
, Edmund V. Capparelli
, Alice Stek
, Sandra K. Burchett
, Diane T. Holland
, Jennifer S. Read
, Elizabeth Smith
,
Chengcheng Hu
, Stephen A. Spector
, James D. Connor
Research output
:
Contribution to journal
›
Article
›
peer-review
46
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Impact of pregnancy on abacavir pharmacokinetics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Abacavir
100%
AIDS Clinical Trials
14%
Antepartum
42%
Antiviral Drugs
28%
Area under the Concentration-time Curve
42%
Cmax
28%
Confidence Interval
57%
Dose Adjustment
14%
Drug Disposition
14%
During Pregnancy
42%
Geometric Mean
14%
Hispanic
14%
Historical Controls
14%
Non-pregnant Women
14%
Pediatric AIDS
14%
Pharmacokinetic Study
14%
Pharmacokinetics
100%
Physiological Changes
14%
Plasma Concentration
14%
Plasma Samples
14%
Pregnant Women
14%
Race-ethnicity
14%
Reversed-phase HPLC
14%
Routine Care
14%
Third Trimester
14%
Twice Daily
14%
Week of Gestation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Abacavir
100%
Clinical Trial
14%
Pharmacokinetics
100%
Reverse Phase High Performance Liquid Chromatography
14%